Table 1.
Characteristics of study population
DCM | OMI | SAP | Control subjects | |
Age (years) | 61(3) | 67(2) | 67(2) | 67(2) |
Men/women | 13/7 | 7/7 | 11/3 | 4/6 |
LVEF (%) | 29(2)* | 30(2)* | 67(2) | 69(3) |
LVDd (mm) | 65(2)* | 61(2)* | 46(2) | 45(1) |
SBP (mm Hg) | 116(3) | 120(5) | 128(5) | 126(4) |
HR (beats/min) | 68(2) | 71(3) | 62(2) | 72(3) |
Serum creatinine (mg/dl) | 1.1(0.1) | 0.9(0.1) | 0.9(0.1) | 0.9(0.1) |
BMI (kg/m2) | 20.8(0.8) | 22.6(0.9) | 23.7(0.8) | 23.4(0.8) |
Hb (g/dl) | 12.8(0.5) | 13.3(0.4) | 12.7(0.3) | 13.4(0.4) |
Medication (n (%)) | ||||
Diuretics | 19 (95) | 11 (79) | ||
Digitalis | 11 (55) | 8 (57) | ||
ACEI/ARB | 16 (80) | 9 (64) | 3(21) | |
β Blockers | 3 (15) | 1 (5) | 3(21) |
Data presented are mean (SEM), or number of patients.
*p<0.001v SAP or control.
ACEI, angiotensin converting enzyme inhibitors; ARB, angiotensin II receptor blockers; BMI, body mass index; DCM, patients with congestive heart failure caused by dilated cardiomyopathy; Hb, haemoglobin; HR, heart rate; LVDd, left ventricular end diastolic diameter; LVEF, left ventricular ejection fraction; OMI, patients with congestive heart failure caused by old myocardial infarction; SAP, patients of stable angina pectoris without congestive heart failure; SBP, systolic blood pressure.